Primary Care Reports
RSSArticles
-
Pharmacology Watch: Atherosclerosis Reversed With Lipid-Lowering Drugs
When it comes to treating lipids in patients with heart disease, the mantra may be, The lower the LDL, the better. Data from the multicenter Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial indicate that aggressive reduction of atherogenic lipoproteins prevents progression of disease. -
Clinical Briefs in Primary Care Supplement
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: The FDA and Merck Fielding Concerns About Vioxx
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market. -
Prevention of Venous Thromboembolism in the Medical Patient: Fact vs. Fiction
Physicians increasingly are aware of the need to provide prophylaxis against venous thrombosis for the medically ill patient in the hospital environment. This article attempts to separate the fact from fiction regarding VTE prophylaxis. -
Pharmacology Watch: Missing Link Between Vaccines and Diabetes
Breast Cancer and the Use of Statins; Warnings Issued for IBS Drugs; FDA Actions -
Clinical Briefs in Primary Care Supplement
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Estrogen Found to Not Affect Heart Disease, Breast Cancer
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end. -
Clinical Briefs in Primary Care Supplement
Sulfonamide Antibiotics and Sulfonamide Nonantibiotics; Autoantibodies Before Onset of SLE; Prevention of VTE with Ximelagatran; Combined Levothyroxine Plus Liothyronine Compared to Levothyroxine Alone in Primary Hypothyroidism; Specific Site Involvement in Fixed Drug Eruption; Anticoagulation Therapy for Stroke Prevention in Patients with Atrial Fibrillation